Shu‐Na Wang

710 total citations
17 papers, 562 citations indexed

About

Shu‐Na Wang is a scholar working on Molecular Biology, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Shu‐Na Wang has authored 17 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Geriatrics and Gerontology and 4 papers in Epidemiology. Recurrent topics in Shu‐Na Wang's work include Pluripotent Stem Cells Research (5 papers), Sirtuins and Resveratrol in Medicine (4 papers) and 3D Printing in Biomedical Research (3 papers). Shu‐Na Wang is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), Sirtuins and Resveratrol in Medicine (4 papers) and 3D Printing in Biomedical Research (3 papers). Shu‐Na Wang collaborates with scholars based in China, France and United States. Shu‐Na Wang's co-authors include Chao‐Yu Miao, Tian‐Ying Xu, Wenlin Li, Ming‐He Cheng, Zhi Wang, Ding‐Feng Su, Zhi Wang, Hong Chen, Pei Wang and Yun‐Feng Guan and has published in prestigious journals such as Scientific Reports, British Journal of Pharmacology and Frontiers in Immunology.

In The Last Decade

Shu‐Na Wang

17 papers receiving 557 citations

Peers

Shu‐Na Wang
Comparison fields: 5 of 87
  • Molecular Biology 317
  • Epidemiology 99
  • Biomedical Engineering 96
  • Neurology 84
  • Cellular and Molecular Neuroscience 74
Replace Abhijit Nirwane with:
Abhijit Nirwane United States
Younghye Moon South Korea
Xiaosong Song China
Jason Callio United States
Yuewen Tang China
Lanhai Lü China
Yuqian Li China
Yanran Liang China
Jingxian Xu China
Abhijit Nirwane United States View profile →
Citations per field, relative to Shu‐Na Wang
Shu‐Na Wang · 1×
Citations per year, relative to Shu‐Na Wang
Shu‐Na Wang · 1×

Countries citing papers authored by Shu‐Na Wang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Na Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Na Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Na Wang more than expected).

Fields of papers citing papers by Shu‐Na Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Na Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Na Wang. The network helps show where Shu‐Na Wang may publish in the future.

Co-authorship network of co-authors of Shu‐Na Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Na Wang. A scholar is included among the top collaborators of Shu‐Na Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Na Wang. Shu‐Na Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 5
2 4
3 7
4 8
5 22
6 25
7 34
8 7
9 52
10 30
11 86
12 27
13 56
14 103
15 31
16 40
17 25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026